MAFLD vs NAFLD: Let the contest begin!
Liver Int
.
2020 Sep;40(9):2079-2081.
doi: 10.1111/liv.14620.
Authors
Cristiana Bianco
1
,
Stefano Romeo
2
3
,
Salvatore Petta
4
,
Michelle T Long
5
,
Luca Valenti
1
6
Affiliations
1
Translational Medicine - Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
2
Deparment of Clinical and Molecular Medicine, University of Gothenburg, Gothenburg, Sweden.
3
Department of Medical and Surgical Science, Magna Graecia University, Catanzaro, Italy.
4
Section of Gastroenterology and Hepatology, PROMISE, Università di Palermo, Palermo, Italy.
5
Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.
6
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
PMID:
32930521
PMCID:
PMC7510483
DOI:
10.1111/liv.14620
No abstract available
Keywords:
fatty liver disease; insulin resistance; metabolism; obesity; steatosis.
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Insulin Resistance*
Non-alcoholic Fatty Liver Disease*
Grants and funding
K23 DK113252/DK/NIDDK NIH HHS/United States
L30 DK106778/DK/NIDDK NIH HHS/United States
UL1 TR001430/TR/NCATS NIH HHS/United States